Azithromycin alleviates the severity of rheumatoid arthritis by targeting the unfolded protein response component of glucose‐regulated protein 78 (GRP78)
- 19 October 2021
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (6) , 1201-1219
Abstract
Background and Purpose: Azithromycin is a macrolide antibiotic with anti‐inflammatory properties. We aim to substantiate the treatment potential of azithromycin in rheumatoid arthritis.Experimental Approach: Gene expression profiles were collected by RNA sequencing and the effects of azithromycin were assessed by in vitro and in vivo assays on the effects of azithromycin‐mediated blockade of glucose‐regulated protein 78 (GRP78). Anti‐inflammatory activity of azithromycin was measured in fibroblast‐like synoviocytes from rheumatoid arthritis patients and in collagen‐induced arthritis in DBA/1 mice. Characterization of the binding of azithromycin to GRP78 was performed using drug affinity responsive target stability, proteomics and cellular thermal shift assays. Azithromycin‐mediated inhibition of GRP78 and its relationship to its anti‐arthritic activity was assessed.Key Results: Azithromycin reduced proinflammatory factor production, cell migration, invasion and chemoattraction and enhanced apoptosis, reducing the deleterious inflammatory response of rheumatoid arthritis fibroblast‐like synoviocytes in vitro. Azithromycin ameliorated the severity of collagen‐induced arthritis lesions as efficiently as the TNFα inhibitor etanercept. Transcriptional analyses suggested that azithromycin treatment impairs signalling cascades associated with cholesterol and lipid biosynthesis. GRP78 was identified as a novel target of azithromycin. Azithromycin‐mediated activation of the unfolded protein response via the inhibition of GRP78 activity is required not only for inducing the expression of C/EBP‐homologous protein (ChOP) but also for the activating sterol‐regulatory element binding protein (SREBP) and its targeted genes involved in cholesterol and lipid biosynthetic processes. Furthermore, deletion of GRP78 abolished the anti‐arthritic activity of azithromycin.Conclusion and Implications: These findings indicate that azithromycin can used to treat rheumatoid arthritis.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2020YQ55)
- National Natural Science Foundation of China (81772760, 81901666, 82072850)
This publication has 59 references indexed in Scilit:
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritisNature Reviews Rheumatology, 2013
- Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotypeCellular Immunology, 2012
- A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritisJournal of Experimental Medicine, 2012
- Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose MetabolismJournal of Biological Chemistry, 2011
- Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis?Proteomics – Clinical Applications, 2010
- Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78International Journal of Cancer, 2010
- GRP78: A Multifunctional Receptor on the Cell SurfaceAntioxidants & Redox Signaling, 2009
- GRP78 expression inhibits insulin and ER stress–induced SREBP-1c activation and reduces hepatic steatosis in miceJournal of Clinical Investigation, 2009
- Amiodarone modulates pharmacokinetics of low‐dose methotrexate in ratsBiopharmaceutics & Drug Disposition, 2008
- Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2The International Journal of Biochemistry & Cell Biology, 2007